APYX Medical study shows Renuvion improves liposuction outcomes

Go back to APYX Medical study shows Renuvion improves liposuction outcomes
(NASDAQ: APYX) Delayed: 3.96 -0.05 (1.25%)
Previous Close $4.01    52 Week High
Open $3.95    52 Week Low
Day High $4.08    P/E N/A 
Day Low $3.95    EPS
Volume 28,579